Search Results 1211-1220 of 17251 for dialysis

  1. A Study of the Impact of Ketamine on Postoperative Cognitive Dysfunction, Delirium, and Renal Dysfunction - Mayo Clinic

    Pre-operative renal dysfunction including a baseline creatinine equal to or greater than 2.0 mg/dL or requiring dialysis; Immunosuppressive medication use ...

  2. Publications - Sidna M. Tulledge-Scheitel, M.D., M.P.H. - Mayo Clinic

    High rates of cancer screening among dialysis patients seen in primary care a cohort study. Prev Med Rep. 2018 Jun; 10:176-183. Epub 2018 Mar 14. View ...

  3. Validation of Gene Expression Markers of Renal Allograft Functional Decline - Mayo Clinic

    About this study. Researchers would like to see if it is possible to predict which transplanted kidneys will do better long term based on the gene ...

  4. Mayo Clinic: Less-Invasive Option as Effective as Esophagus Removal in Early Esophageal Cancer

    Dialysis for the Elderly: New Evidence from Mayo Clinic to Guide Shared Decision-Making · New CDC Analysis Finds Nearly 1 in 4 US Adults Has Arthritis. Related ...

  5. A Phase 1b/2a Multicenter, Open-Label, Dose-Escalation Study to Determine the Maximum Tolerated Dose, Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of CC-220 as Monotherapy and in Combination with Other Treatments in Subjects with Multiple Myeloma - Mayo Clinic

    Subjects with serious renal impairment creatinine clearance ([CrCl] < 45 mL/min) or requiring dialysis would be excluded. Subjects with peripheral ...

  6. Publications - Raymond C. Shields, M.D. - Mayo Clinic

    Predictors of early mortality and readmissions among dialysis patients undergoing lower extremity amputation. J Vasc Surg. 2018 Nov; 68 (5):1505-1516 Epub ...

  7. Mayo Clinic

    Your GivingTuesday gift can go 2X as far. Give Now · Find a doctor · Explore careers · Sign up for free e-newsletters ...

  8. A Study to Evaluate the Safety, Pharmacokinetics, and Anti-tumor Activity of LYT-200 Alone and Combined with Chemotherapy or Tislelizumab to Treat Patients with Metastatic Solid Tumors - Mayo Clinic

    Patients undergoing dialysis. For patients enrolled into anti-PD-1 mAb combination cohorts, no prior exposure to any anti-PD-1 agent in any prior lines of ...

  9. Study to Investigate the Safety and Effectiveness of Two Doses of the Antibody Drug GSK2857916 in Relapsed/Refractory Multiple Myeloma Patients - Mayo Clinic

    Presence of active renal condition (infection, requirement for dialysis or any other condition that could affect subject's safety). Subjects with isolated ...

  10. Prevention of Delayed Graft Function Using Eculizumab Therapy (PROTECT Study) - Mayo Clinic

    Subject with dialysis dependent renal failure (initiated more than 2 months prior to transplant); Subject is to receive a first kidney transplant from a SCD ...